The Glutamic-Pyruvic Transaminase (GPT) Activity Assay Kit is widely used in clinical diagnostics to assess liver function and detect liver damage or disease. It measures the activity of GPT, an enzyme found predominantly in the liver, which is released into the bloodstream during liver injury. Elevated GPT levels are indicative of conditions such as hepatitis, cirrhosis, or drug-induced liver damage. This kit is also employed in research settings to study liver metabolism, toxicity, and the effects of therapeutic agents on liver health. Additionally, it serves as a valuable tool in veterinary medicine for diagnosing liver disorders in animals. The assay is simple, reliable, and provides critical insights into liver-related pathologies.